ID   PP1B_HUMAN              Reviewed;         327 AA.
AC   P62140; B2R5V4; D6W565; P37140; Q5U087; Q6FG45;
DT   21-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   15-MAR-2017, entry version 153.
DE   RecName: Full=Serine/threonine-protein phosphatase PP1-beta catalytic subunit;
DE            Short=PP-1B;
DE            Short=PPP1CD;
DE            EC=3.1.3.16;
DE            EC=3.1.3.53;
GN   Name=PPP1CB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8312365; DOI=10.1016/0167-4889(94)90138-4;
RA   Barker H.M., Brewis N.D., Street A.J., Spurr N.K., Cohen P.T.W.;
RT   "Three genes for protein phosphatase 1 map to different human
RT   chromosomes: sequence, expression and gene localisation of protein
RT   serine/threonine phosphatase 1 beta (PPP1CB).";
RL   Biochim. Biophys. Acta 1220:212-218(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=7796987; DOI=10.1007/BF00410284;
RA   Prochazka M., Mochizuki H., Baier L.J., Cohen P.T.W., Bogardus C.;
RT   "Molecular and linkage analysis of type-1 protein phosphatase
RT   catalytic beta-subunit gene: lack of evidence for its major role in
RT   insulin resistance in Pima Indians.";
RL   Diabetologia 38:461-466(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Umbilical vein;
RX   PubMed=10906760;
RX   DOI=10.1002/1097-4644(2000)79:1<113::AID-JCB110>3.0.CO;2-9;
RA   Verin A.D., Csortos C., Durbin S.D., Aydanyan A., Wang P.,
RA   Patterson C.E., Garcia J.G.;
RT   "Characterization of the protein phosphatase 1 catalytic subunit in
RT   endothelium: involvement in contractile responses.";
RL   J. Cell. Biochem. 79:113-125(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Endometrium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-14, AND ACETYLATION AT ALA-2.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   INTERACTION WITH PPP1R12C.
RX   PubMed=11399775; DOI=10.1074/jbc.M102615200;
RA   Tan I., Ng C.H., Lim L., Leung T.;
RT   "Phosphorylation of a novel myosin binding subunit of protein
RT   phosphatase 1 reveals a conserved mechanism in the regulation of actin
RT   cytoskeleton.";
RL   J. Biol. Chem. 276:21209-21216(2001).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11739654;
RA   Trinkle-Mulcahy L., Sleeman J.E., Lamond A.I.;
RT   "Dynamic targeting of protein phosphatase 1 within the nuclei of
RT   living mammalian cells.";
RL   J. Cell Sci. 114:4219-4228(2001).
RN   [14]
RP   INTERACTION WITH PPP1R15A.
RX   PubMed=11564868; DOI=10.1128/MCB.21.20.6841-6850.2001;
RA   Connor J.H., Weiser D.C., Li S., Hallenbeck J.M., Shenolikar S.;
RT   "Growth arrest and DNA damage-inducible protein GADD34 assembles a
RT   novel signaling complex containing protein phosphatase 1 and inhibitor
RT   1.";
RL   Mol. Cell. Biol. 21:6841-6850(2001).
RN   [15]
RP   INTERACTION WITH PPP1R7.
RX   PubMed=12226088; DOI=10.1074/jbc.M206838200;
RA   Ceulemans H., Vulsteke V., De Maeyer M., Tatchell K., Stalmans W.,
RA   Bollen M.;
RT   "Binding of the concave surface of the Sds22 superhelix to the alpha
RT   4/alpha 5/alpha 6-triangle of protein phosphatase-1.";
RL   J. Biol. Chem. 277:47331-47337(2002).
RN   [16]
RP   ENZYME REGULATION.
RX   PubMed=15705855; DOI=10.1126/science.1101902;
RA   Boyce M., Bryant K.F., Jousse C., Long K., Harding H.P., Scheuner D.,
RA   Kaufman R.J., Ma D., Coen D.M., Ron D., Yuan J.;
RT   "A selective inhibitor of eIF2alpha dephosphorylation protects cells
RT   from ER stress.";
RL   Science 307:935-939(2005).
RN   [17]
RP   INTERACTION WITH PPP1R16B.
RX   PubMed=18586956; DOI=10.1152/ajplung.00325.2007;
RA   Csortos C., Czikora I., Bogatcheva N.V., Adyshev D.M., Poirier C.,
RA   Olah G., Verin A.D.;
RT   "TIMAP is a positive regulator of pulmonary endothelial barrier
RT   function.";
RL   Am. J. Physiol. 295:L440-L450(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-316, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION IN THE MLL5-L COMPLEX.
RX   PubMed=19377461; DOI=10.1038/nature07954;
RA   Fujiki R., Chikanishi T., Hashiba W., Ito H., Takada I., Roeder R.G.,
RA   Kitagawa H., Kato S.;
RT   "GlcNAcylation of a histone methyltransferase in retinoic-acid-induced
RT   granulopoiesis.";
RL   Nature 459:455-459(2009).
RN   [20]
RP   IDENTIFICATION IN THE PTW/PP1 PHOSPHATASE COMPLEX, FUNCTION, AND
RP   INTERACTION WITH PPP1R8.
RX   PubMed=20516061; DOI=10.1074/jbc.M110.109801;
RA   Lee J.H., You J., Dobrota E., Skalnik D.G.;
RT   "Identification and characterization of a novel human PP1 phosphatase
RT   complex.";
RL   J. Biol. Chem. 285:24466-24476(2010).
RN   [21]
RP   INTERACTION WITH NUAK1 AND PPP1R12A.
RX   PubMed=20354225; DOI=10.1126/scisignal.2000616;
RA   Zagorska A., Deak M., Campbell D.G., Banerjee S., Hirano M.,
RA   Aizawa S., Prescott A.R., Alessi D.R.;
RT   "New roles for the LKB1-NUAK pathway in controlling myosin phosphatase
RT   complexes and cell adhesion.";
RL   Sci. Signal. 3:RA25-RA25(2010).
RN   [22]
RP   INTERACTION WITH TRIM28.
RX   PubMed=20424263; DOI=10.1126/scisignal.2000781;
RA   Li X., Lin H.H., Chen H., Xu X., Shih H.M., Ann D.K.;
RT   "SUMOylation of the transcriptional co-repressor KAP1 is regulated by
RT   the serine and threonine phosphatase PP1.";
RL   Sci. Signal. 3:RA32-RA32(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   FUNCTION IN CIRCADIAN CLOCK.
RX   PubMed=21712997; DOI=10.1371/journal.pone.0021325;
RA   Schmutz I., Wendt S., Schnell A., Kramer A., Mansuy I.M., Albrecht U.;
RT   "Protein phosphatase 1 (PP1) is a post-translational regulator of the
RT   mammalian circadian clock.";
RL   PLoS ONE 6:E21325-E21325(2011).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-316, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   FUNCTION, INTERACTION WITH FOXP3, AND INDUCTION.
RX   PubMed=23396208; DOI=10.1038/nm.3085;
RA   Nie H., Zheng Y., Li R., Guo T.B., He D., Fang L., Liu X., Xiao L.,
RA   Chen X., Wan B., Chin Y.E., Zhang J.Z.;
RT   "Phosphorylation of FOXP3 controls regulatory T cell function and is
RT   inhibited by TNF-alpha in rheumatoid arthritis.";
RL   Nat. Med. 19:322-328(2013).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [30]
RP   VARIANTS ARG-49 AND PRO-56, AND INVOLVEMENT IN SUSCEPTIBILITY TO
RP   RASOPATHY REMINISCENT OF NSLH.
RX   PubMed=27264673; DOI=10.1002/ajmg.a.37781;
RA   Gripp K.W., Aldinger K.A., Bennett J.T., Baker L., Tusi J.,
RA   Powell-Hamilton N., Stabley D., Sol-Church K., Timms A.E.,
RA   Dobyns W.B.;
RT   "A novel rasopathy caused by recurrent de novo missense mutations in
RT   PPP1CB closely resembles Noonan syndrome with loose anagen hair.";
RL   Am. J. Med. Genet. A 170:2237-2247(2016).
CC   -!- FUNCTION: Protein phosphatase that associates with over 200
CC       regulatory proteins to form highly specific holoenzymes which
CC       dephosphorylate hundreds of biological targets. Protein
CC       phosphatase (PP1) is essential for cell division, it participates
CC       in the regulation of glycogen metabolism, muscle contractility and
CC       protein synthesis. Involved in regulation of ionic conductances
CC       and long-term synaptic plasticity. Component of the PTW/PP1
CC       phosphatase complex, which plays a role in the control of
CC       chromatin structure and cell cycle progression during the
CC       transition from mitosis into interphase. In balance with CSNK1D
CC       and CSNK1E, determines the circadian period length, through the
CC       regulation of the speed and rhythmicity of PER1 and PER2
CC       phosphorylation. May dephosphorylate CSNK1D and CSNK1E.
CC       Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-
CC       cells (Treg) from patients with rheumatoid arthritis, thereby
CC       inactivating FOXP3 and rendering Treg cells functionally defective
CC       (PubMed:23396208). {ECO:0000269|PubMed:20516061,
CC       ECO:0000269|PubMed:21712997, ECO:0000269|PubMed:23396208}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- CATALYTIC ACTIVITY: [Myosin light-chain] phosphate + H(2)O =
CC       [myosin light-chain] + phosphate.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000250};
CC       Note=Binds 2 manganese ions per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Inhibited by the toxins okadaic acid,
CC       tautomycin and microcystin Leu-Arg (By similarity). The
CC       phosphatase activity of the PPP1R15A-PP1 complex toward EIF2S1 is
CC       specifically inhibited by Salubrinal, a drug that protects cells
CC       from endoplasmic reticulum stress. {ECO:0000250,
CC       ECO:0000269|PubMed:15705855}.
CC   -!- SUBUNIT: PP1 comprises a catalytic subunit, PPP1CA, PPP1CB or
CC       PPP1CC, which is folded into its native form by inhibitor 2 and
CC       glycogen synthetase kinase 3, and then complexed to one or several
CC       targeting or regulatory subunits. The targeting or regulatory
CC       subunits determine the substrate specificity of PP1. PPP1R12A,
CC       PPP1R12B and PPP1R12C mediate binding to myosin. PPP1R3A (in
CC       skeletal muscle), PPP1R3B (in liver), PPP1R3C, PPP1R3D and PPP1R3F
CC       (in brain) mediate binding to glycogen. Part of a complex
CC       containing PPP1R15B, PP1 and NCK1/2 (By similarity). Component of
CC       the MLL5-L complex, at least composed of KMT2E/MLL5, STK38,
CC       PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT. Interacts with PPP1R7
CC       and PPP1R12C. PPP1R15A and PPP1R15B mediate binding to EIF2S1.
CC       Interacts with PPP1R16B. Component of the PTW/PP1 phosphatase
CC       complex, composed of PPP1R10/PNUTS, TOX4, WDR82, and PPP1CA or
CC       PPP1CB or PPP1CC. Interacts with PPP1R8. Interacts with TRIM28;
CC       the interaction is weak. Interacts with PPP1R12A and NUAK1; the
CC       interaction is direct. Interacts with FOXP3.
CC       {ECO:0000250|UniProtKB:P62141, ECO:0000269|PubMed:11399775,
CC       ECO:0000269|PubMed:11564868, ECO:0000269|PubMed:12226088,
CC       ECO:0000269|PubMed:18586956, ECO:0000269|PubMed:19377461,
CC       ECO:0000269|PubMed:20354225, ECO:0000269|PubMed:20424263,
CC       ECO:0000269|PubMed:20516061, ECO:0000269|PubMed:23396208}.
CC   -!- INTERACTION:
CC       P35609:ACTN2; NbExp=3; IntAct=EBI-352350, EBI-77797;
CC       P38398:BRCA1; NbExp=3; IntAct=EBI-352350, EBI-349905;
CC       O08785:Clock (xeno); NbExp=2; IntAct=EBI-352350, EBI-79859;
CC       Q9H175:CSRNP2; NbExp=5; IntAct=EBI-352350, EBI-5235958;
CC       Q8WUF5:PPP1R13L; NbExp=3; IntAct=EBI-352350, EBI-5550163;
CC       Q96I34:PPP1R16A; NbExp=8; IntAct=EBI-352350, EBI-710402;
CC       Q6NXS1:PPP1R2P3; NbExp=5; IntAct=EBI-352350, EBI-10251630;
CC       Q9UQK1:PPP1R3C; NbExp=5; IntAct=EBI-352350, EBI-2506727;
CC       Q15435:PPP1R7; NbExp=6; IntAct=EBI-352350, EBI-1024281;
CC       Q9H788:SH2D4A; NbExp=11; IntAct=EBI-352350, EBI-747035;
CC       Q13625-3:TP53BP2; NbExp=3; IntAct=EBI-352350, EBI-10175039;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11739654}.
CC       Nucleus {ECO:0000269|PubMed:11739654}. Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:11739654}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:11739654}. Note=Highly mobile in cells and can
CC       be relocalized through interaction with targeting subunits. In the
CC       presence of PPP1R8 relocalizes from the nucleus to nuclear
CC       speckles.
CC   -!- INDUCTION: Up-regulated in synovial fluid mononuclear cells and
CC       peripheral blood mononuclear cells from patients with rheumatoid
CC       arthritis. {ECO:0000269|PubMed:23396208}.
CC   -!- DISEASE: Note=Variants in PPP1CB may be a cause of susceptibility
CC       to rasopathy reminiscent of Noonan syndrome-like disorder with
CC       loose anagen hair (NSLH). Affected individuals show Noonan
CC       dysmorphic features such as macrocephaly, high forehead and low-
CC       set and posteriorly rotated ears, in association with some hair
CC       abnormality (slow-growing, very fine hair or unruly hair texture),
CC       developmental delay and mild ventriculomegaly.
CC       {ECO:0000269|PubMed:27264673}.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=The things we forget -
CC       Issue 32 of March 2003;
CC       URL="http://web.expasy.org/spotlight/back_issues/032";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X80910; CAA56870.1; -; mRNA.
DR   EMBL; U11005; AAA85093.1; -; Genomic_DNA.
DR   EMBL; U10998; AAA85093.1; JOINED; Genomic_DNA.
DR   EMBL; U10999; AAA85093.1; JOINED; Genomic_DNA.
DR   EMBL; U11000; AAA85093.1; JOINED; Genomic_DNA.
DR   EMBL; U11001; AAA85093.1; JOINED; Genomic_DNA.
DR   EMBL; U11002; AAA85093.1; JOINED; Genomic_DNA.
DR   EMBL; U11003; AAA85093.1; JOINED; Genomic_DNA.
DR   EMBL; U11004; AAA85093.1; JOINED; Genomic_DNA.
DR   EMBL; AF092905; AAF01137.1; -; mRNA.
DR   EMBL; CR542263; CAG47059.1; -; mRNA.
DR   EMBL; CR542285; CAG47080.1; -; mRNA.
DR   EMBL; BT019744; AAV38549.1; -; mRNA.
DR   EMBL; AK312329; BAG35251.1; -; mRNA.
DR   EMBL; BX647970; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC097724; AAY24124.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00527.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00528.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00529.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAX00530.1; -; Genomic_DNA.
DR   EMBL; BC002697; AAH02697.1; -; mRNA.
DR   EMBL; BC012045; AAH12045.1; -; mRNA.
DR   CCDS; CCDS33169.1; -.
DR   PIR; S41052; S41052.
DR   RefSeq; NP_002700.1; NM_002709.2.
DR   RefSeq; NP_996759.1; NM_206876.1.
DR   UniGene; Hs.702907; -.
DR   ProteinModelPortal; P62140; -.
DR   SMR; P62140; -.
DR   BioGrid; 111494; 237.
DR   DIP; DIP-33220N; -.
DR   IntAct; P62140; 223.
DR   MINT; MINT-208135; -.
DR   STRING; 9606.ENSP00000296122; -.
DR   DEPOD; P62140; -.
DR   iPTMnet; P62140; -.
DR   PhosphoSitePlus; P62140; -.
DR   SwissPalm; P62140; -.
DR   BioMuta; PPP1CB; -.
DR   DMDM; 49065814; -.
DR   OGP; P37140; -.
DR   EPD; P62140; -.
DR   PaxDb; P62140; -.
DR   PeptideAtlas; P62140; -.
DR   PRIDE; P62140; -.
DR   TopDownProteomics; P62140; -.
DR   DNASU; 5500; -.
DR   Ensembl; ENST00000296122; ENSP00000296122; ENSG00000213639.
DR   Ensembl; ENST00000358506; ENSP00000351298; ENSG00000213639.
DR   Ensembl; ENST00000395366; ENSP00000378769; ENSG00000213639.
DR   GeneID; 5500; -.
DR   KEGG; hsa:5500; -.
DR   CTD; 5500; -.
DR   GeneCards; PPP1CB; -.
DR   HGNC; HGNC:9282; PPP1CB.
DR   HPA; CAB022558; -.
DR   HPA; CAB069426; -.
DR   HPA; HPA065425; -.
DR   MIM; 600590; gene.
DR   neXtProt; NX_P62140; -.
DR   OpenTargets; ENSG00000213639; -.
DR   PharmGKB; PA33610; -.
DR   eggNOG; ENOG410IN85; Eukaryota.
DR   eggNOG; ENOG410XPVF; LUCA.
DR   GeneTree; ENSGT00530000062911; -.
DR   HOGENOM; HOG000172697; -.
DR   HOVERGEN; HBG000216; -.
DR   InParanoid; P62140; -.
DR   KO; K06269; -.
DR   OMA; EFVRSCR; -.
DR   OrthoDB; EOG091G0EKF; -.
DR   PhylomeDB; P62140; -.
DR   TreeFam; TF354243; -.
DR   Reactome; R-HSA-163560; Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   SIGNOR; P62140; -.
DR   ChiTaRS; PPP1CB; human.
DR   GeneWiki; PPP1CB; -.
DR   GenomeRNAi; 5500; -.
DR   PRO; PR:P62140; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000213639; -.
DR   CleanEx; HS_PPP1CB; -.
DR   ExpressionAtlas; P62140; baseline and differential.
DR   Genevisible; P62140; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0042587; C:glycogen granule; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000164; C:protein phosphatase type 1 complex; IEA:Ensembl.
DR   GO; GO:0072357; C:PTW/PP1 phosphatase complex; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0017018; F:myosin phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0050115; F:myosin-light-chain-phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0016791; F:phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0005977; P:glycogen metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0005979; P:regulation of glycogen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0005981; P:regulation of glycogen catabolic process; IEA:Ensembl.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_ApaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   InterPro; IPR031675; STPPase_N.
DR   Pfam; PF00149; Metallophos; 1.
DR   Pfam; PF16891; STPPase_N; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Biological rhythms; Carbohydrate metabolism; Cell cycle;
KW   Cell division; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Glycogen metabolism;
KW   Hydrolase; Manganese; Metal-binding; Nucleus; Phosphoprotein;
KW   Protein phosphatase; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801}.
FT   CHAIN         2    327       Serine/threonine-protein phosphatase PP1-
FT                                beta catalytic subunit.
FT                                /FTId=PRO_0000058779.
FT   ACT_SITE    124    124       Proton donor. {ECO:0000250}.
FT   METAL        63     63       Manganese 1. {ECO:0000250}.
FT   METAL        65     65       Manganese 1. {ECO:0000250}.
FT   METAL        91     91       Manganese 1. {ECO:0000250}.
FT   METAL        91     91       Manganese 2. {ECO:0000250}.
FT   METAL       123    123       Manganese 2. {ECO:0000250}.
FT   METAL       172    172       Manganese 2. {ECO:0000250}.
FT   METAL       247    247       Manganese 2. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801}.
FT   MOD_RES     316    316       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      49     49       P -> R (probable disease-associated
FT                                mutation found in patients with rasopathy
FT                                reminiscent of NSLH).
FT                                {ECO:0000269|PubMed:27264673}.
FT                                /FTId=VAR_076839.
FT   VARIANT      56     56       A -> P (probable disease-associated
FT                                mutation found in patients with rasopathy
FT                                reminiscent of NSLH).
FT                                {ECO:0000269|PubMed:27264673}.
FT                                /FTId=VAR_076840.
FT   CONFLICT     51     51       L -> P (in Ref. 5; AAV38549).
FT                                {ECO:0000305}.
SQ   SEQUENCE   327 AA;  37187 MW;  E8356022E9B94ECD CRC64;
     MADGELNVDS LITRLLEVRG CRPGKIVQMT EAEVRGLCIK SREIFLSQPI LLELEAPLKI
     CGDIHGQYTD LLRLFEYGGF PPEANYLFLG DYVDRGKQSL ETICLLLAYK IKYPENFFLL
     RGNHECASIN RIYGFYDECK RRFNIKLWKT FTDCFNCLPI AAIVDEKIFC CHGGLSPDLQ
     SMEQIRRIMR PTDVPDTGLL CDLLWSDPDK DVQGWGENDR GVSFTFGADV VSKFLNRHDL
     DLICRAHQVV EDGYEFFAKR QLVTLFSAPN YCGEFDNAGG MMSVDETLMC SFQILKPSEK
     KAKYQYGGLN SGRPVTPPRT ANPPKKR
//
